本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Adverum Biotechnologies, Inc.

3.52
+0.350011.04%
盤後3.590.0700+1.99%19:34 EDT
成交量:17.26萬
成交額:59.17萬
市值:7,386.42萬
市盈率:-0.43
高:3.57
開:3.22
低:3.18
收:3.17
52周最高:8.56
52周最低:1.78
股本:2,098.42萬
流通股本:1,136.27萬
量比:3.58
換手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-8.1048
每股收益(LYR):-6.6185
淨資產收益率:-229.34%
總資產收益率:-62.55%
市淨率:-3.65
市盈率(LYR):-0.53

資料載入中...

2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/04/28

SEC問詢函

Form CORRESP - Correspondence
2023/04/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/30

重要事件披露

8-K - Current report
2023/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/13

重要事件披露

8-K - Current report
2022/11/25

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]